<SEC-DOCUMENT>0001640334-25-001622.txt : 20250904
<SEC-HEADER>0001640334-25-001622.hdr.sgml : 20250904
<ACCEPTANCE-DATETIME>20250904072439
ACCESSION NUMBER:		0001640334-25-001622
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250904
DATE AS OF CHANGE:		20250904

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARTELO BIOSCIENCES, INC.
		CENTRAL INDEX KEY:			0001621221
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				331220924
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-273153
		FILM NUMBER:		251291888

	BUSINESS ADDRESS:	
		STREET 1:		505 LOMAS SANTA FE, SUITE 160
		CITY:			SOLANA BEACH
		STATE:			CA
		ZIP:			92075
		BUSINESS PHONE:		858-925-7049

	MAIL ADDRESS:	
		STREET 1:		505 LOMAS SANTA FE, SUITE 160
		CITY:			SOLANA BEACH
		STATE:			CA
		ZIP:			92075

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	REACTIVE MEDICAL INC.
		DATE OF NAME CHANGE:	20170207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KNIGHT KNOX DEVELOPMENT CORP.
		DATE OF NAME CHANGE:	20141001
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>artl_424b5.htm
<DESCRIPTION>424B5
<TEXT>
<html><head><title>artl_424b5.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman; MARGIN: 0px 7%"><p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>Filed Pursuant to Rule 424(b)(5)</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>Registration No. 333-273153</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>PROSPECTUS SUPPLEMENT</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(To Prospectus dated July 14, 2023)</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Up to $3,451,527 </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares of Common Stock</strong>&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="artl_424b5img1.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This prospectus supplement amends and supplements the information in the prospectus supplement, dated July 18, 2025 (the &#8220;ATM Prospectus&#8221;), relating to the offer and sale of up to $6,500,000 &nbsp;shares of our common stock, $0.001 par value per share (&#8220;Common Stock&#8221;), pursuant to the At the Market Offering Agreement between us and R.F. Lafferty &amp; Co., Inc., as exclusive sales agent (who we refer to herein as &#8220;Lafferty&#8221; or the &#8220;Sales Agent&#8221;), dated July 18, 2025 (the &#8220;Sales Agreement&#8221;). This prospectus supplement should be read in conjunction with the ATM Prospectus and the base prospectus, dated July 7, 2023 (the &#8220;Base Prospectus&#8221;), and is qualified by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the ATM Prospectus or the Base Prospectus. This prospectus supplement is not complete without and may only be delivered or utilized in connection with the ATM Prospectus and the Base Prospectus and any future amendments or supplements thereto.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Common Stock is listed on The Nasdaq Capital Market tier of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) under the symbol &#8220;ARTL.&#8221; As of September 3, 2025, the last reported sales price of the Common Stock on Nasdaq was $8.76.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We are filing this prospectus supplement to supplement and amend, as of September 4, 2025, the ATM Prospectus and the Base Prospectus, to reduce the maximum aggregate gross sales price of our Common Stock that may be offered, issued and sold under the Sales Agreement from and after the date hereof to $3,451,527 (the &#8220;ATM Offering Size Reduction&#8221;), including the Common Stock previously sold. Under the ATM Prospectus, we initially registered up to $6,500,000 of our Common Stock for offer and sale pursuant to the Sales Agreement. As of the date of the filing of this prospectus supplement, we have sold $451,526.95 shares of Common Stock that are covered by the ATM Prospectus. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The purpose of this prospectus supplement is to update the ATM Prospectus to reflect the ATM Offering Size Reduction. Except as modified by this prospectus supplement, the terms of the ATM offering remain unchanged, and the Sales Agreement remains in full force and effect.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The aggregate market value of our outstanding shares of Common Stock held by non-affiliates as of September 3, 2025, is $22,062,306, based on 777,881 shares of Common Stock outstanding, of which 774,116 are held by non-affiliates, and a closing price on Nasdaq of $28.50 on July 10, 2025, which is within 60 days of the date of this prospectus supplement. Upon any sale of shares of Common Stock under this prospectus supplement pursuant to General Instruction I.B.6. of Form S-3, in no event will we sell shares pursuant to this prospectus supplement having a value exceeding more than one-third of our public float in any 12-month period so long as our public float remains below $75,000,000. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Investing in our shares of Common Stock involves a high degree of risk and uncertainty. See &#8220;Risk Factors&#8221; beginning on page S-9 of the ATM Prospectus and the other documents that are incorporated by reference in the ATM Prospectus and the accompanying base prospectus.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUS SUPPLEMENT, THE PRIOR PROSPECTUS SUPPLEMENTS OR THE ACCOMPANYING PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:18pt">R.F. Lafferty &amp; Co., Inc.</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">______________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The date of this prospectus supplement is September 4, 2025.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>artl_424b5img1.jpg
<TEXT>
begin 644 artl_424b5img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !, -4# 2(  A$! Q$!_\0
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MMJ-K>?5ERYN:Z1\2V=Y<Z;J-MJ%G*T-U:RK-%(O5'4Y!'T(K]-? ?BFW\;>
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M,UZ1\0&ME^'?B W6T1_8I -W]\CY/QW8Q[UG^/O"VE>*="QJ2R+):2EH982
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%%&A1_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
